<div id="readability-page-1"><p>Cantor Fitzgerald analyst Olivia Brayer maintained a Buy rating on Vanda yesterday and set a price target of $11.00.</p><h3>Claim 50% Off TipRanks Premium and Invest with Confidence </h3><ul><li>Unlock  hedge-fund level data  and  powerful investing tools  designed to help you make smarter, sharper decisions  </li><li> Stay ahead of the market with  the latest news and analysis  so your portfolio is always positioned for maximum potential</li></ul> <p>Brayer covers the Healthcare sector, focusing on stocks such as CytomX Therapeutics, BioMarin Pharmaceutical, and Insmed. According to TipRanks, Brayer has an average return of <span>7.5%</span> and a 45.31% success rate on recommended stocks. </p> <p>In a report released yesterday, H.C. Wainwright also reiterated a Buy rating on the stock with a $20.00 price target.</p></div>

VNDA

<p>Cantor Fitzgerald analyst Olivia Brayer maintained a Buy rating for Vanda (VNDA) with a price target of $11.00. H.C. Wainwright also reiterated a Buy rating with a $20.00 target. Brayer, focusing on healthcare stocks, has an average return of 7.5% and a 45.31% success rate according to TipRanks.</p>

Cantor Fitzgerald Sticks to Their Buy Rating for Vanda (VNDA)